Horn, Julia <br/><br/>
Treatment option of bendamustine in combination with rituximab in elderly and frail patients with aggressive B-non-Hodgkin lymphoma: rational, efficacy, and tolerance.  [electronic resource] 

 -  Annals of hematology  Oct 2012 
 - 1579-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-012-1503-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bendamustine Hydrochloride<br/>Drug Tolerance<br/>Female<br/>Follow-Up Studies<br/>Frail Elderly<br/>Humans<br/>Lymphoma, B-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Invasiveness--pathology<br/>Nitrogen Mustard Compounds--administration & dosage<br/>Rituximab<br/>Survival Rate--trends<br/>Treatment Outcome